Synthomics
Founded Year
2013Stage
Acquired | AcquiredTotal Raised
$5.69MAbout Synthomics
Developer of instrumentation for gene synthesis analysis. The company develops a DNA and RNA synthesizer for molecular biology research purposes. The platform aims to deliver less expensive, higher quality, reduced turn-around-time oligonucleotide synthesis solutions. It was founded in 2013 and is based in Menlo Park, California.
Loading...
Loading...
Synthomics Patents
Synthomics has filed 1 patent.
The 3 most popular patent topics include:
- biotechnology
- fluid dynamics
- genetics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/31/2019 | 10/17/2023 | Biotechnology, Molecular biology, Fluid dynamics, Genetics, Genomics | Grant |
Application Date | 1/31/2019 |
|---|---|
Grant Date | 10/17/2023 |
Title | |
Related Topics | Biotechnology, Molecular biology, Fluid dynamics, Genetics, Genomics |
Status | Grant |
Synthomics Frequently Asked Questions (FAQ)
When was Synthomics founded?
Synthomics was founded in 2013.
Where is Synthomics's headquarters?
Synthomics's headquarters is located at 3477 Edison Way, Menlo Park.
What is Synthomics's latest funding round?
Synthomics's latest funding round is Acquired.
How much did Synthomics raise?
Synthomics raised a total of $5.69M.
Who are the investors of Synthomics?
Investors of Synthomics include True Ventures, CSC Upshot Ventures, Genoa Ventures and National Institutes of Health.
Who are Synthomics's competitors?
Competitors of Synthomics include Catalog Technologies.
Loading...
Compare Synthomics to Competitors
DNA Script is a company focused on revolutionizing DNA synthesis with enzymes in the biotechnology industry. The company's main service is the production of custom DNA oligos using their proprietary Enzymatic DNA Synthesis (EDS) technology, which allows for on-demand, in-house production without the need for specialized training or skills. DNA Script primarily sells to sectors such as genomics research and personalized medicine. It was founded in 2014 and is based in Le Kremlin-Bicetre, France.
Evonetix develops a desktop, short-latency solution to synthesize DNA to facilitate the field of synthetic biology, with applications across industries including healthcare, pharma, biotech, food and agriculture, and data storage. It leverages semiconductor-controlled synthesis on silicon which enables ultra-parallel DNA preparation, and moving capacity from remote service centers. The company was founded in 2015 and is based in Cambridge, United Kingdom.
Molecular Assemblies is a private life sciences company that focuses on the development of enzymatic DNA synthesis technology. The company's main service is the production of long, high quality, sequence-specific DNA using its patented Fully Enzymatic Synthesis (FES) technology. This technology is primarily used in industries such as industrial synthetic biology, precision medicine, data information storage, nanomachines, and bio-based electronics. It was founded in 2013 and is based in San Diego, California.
Helixworks Technologies operates as a biotechnology company. It specializes in deoxyribonucleic acid (DNA) synthesis. The company was founded in 2013 and is based in Cork, Ireland.
Iridia is a deoxyribonucleic acid (DNA) data storage platform. It stores medical records, financial information, and other sensitive data in a secure way. It was founded in 2016 and is based in Carlsbad, California.
Catalog develops technology to store digital information in deoxyribonucleic acid (DNA) molecules. It provides a platform for digital deoxyribonucleic acid (DNA) data storage and computation. It was founded in 2016 and is based in Boston, Massachusetts.
Loading...